Mad at DryShips Inc. (DRYS)? Join the Club
DryShips Inc. (NASDAQ:DRYS) has been the recipient of numerous legal actions and investigations.
Valeant Pharmaceuticals Intl Inc: The Problem with Branded Rx
The closing of the $820 million divestiture of Dendreon to Sanpower Group boosts Valeant Pharmaceuticals Intl Inc (NYSE:VRX) liquidity position, but it does nothing …
Explaining Bitcoin Investment Trust’s (GBTC) Premium Over NAV
The Bitcoin Investment Trust (OTCMKTS:GBTC) is the first publicly traded security designed to track the performance of Bitcoin, and it does so for …
Tesla Inc (TSLA): The Model 3 Vs. the Model S
New details emerge about Tesla Inc (NASDAQ:TSLA) Model 3 sedan, the new mass-market electric vehicle expected to be available by the end of …
Valeant Pharmaceuticals Intl Inc (VRX) Risk/Reward Remains Problematic
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a difficult stock to value. Unlike a ‘regular’ company with a stock price reflecting cash flow, EPS, …
DryShips Inc. (DRYS) New Credit Facility Won’t Stop the Stock from Sinking
DryShips Inc. (NASDAQ:DRYS) looks like it is in a death spiral, and after countless dilutions and stock splits, even the most stubborn bulls …
Why Apple Inc. (AAPL) Doesn’t Need to Repatriate Its Cash
Trump’s victory in the U.S presidential election put a new gust of wind in Apple Inc.
Snap Inc (SNAP) Business Model Is Flawed; Here’s Why
I was widely encouraged to invest in Snap Inc (NYSE:SNAP) when the stock IPOed in March. Many of my friends made the mistake …
Apple Inc. (AAPL): Establishing a Foothold in India
Apple Inc. (NASDAQ:AAPL) international iPhone sales are in trouble because of China where revenue fell 14% year-on-year in the March quarter.
Valeant Pharmaceuticals Intl Inc (VRX) Struggles with Generic Competition
Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) Branded Rx division has been making headlines as the embattled drugmaker struggles to prevent generic competition from eroding …